Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026)

Zai Lab's Other Accumulated Expenses history spans 9 years, with the latest figure at $63.7 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 8.45% to $63.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.7 million, a 8.45% increase, with the full-year FY2025 number at $63.7 million, up 8.45% from a year prior.
  • Other Accumulated Expenses hit $63.7 million in Q4 2025 for Zai Lab, up from $51.5 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ZLAB hit a ceiling of $83.0 million in Q4 2023 and a floor of $36.8 million in Q1 2025.
  • Historically, Other Accumulated Expenses has averaged $55.1 million across 5 years, with a median of $54.0 million in 2021.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 101.39% in 2021 and later dropped 29.23% in 2024.
  • Tracing ZLAB's Other Accumulated Expenses over 5 years: stood at $60.8 million in 2021, then grew by 9.88% to $66.8 million in 2022, then increased by 24.18% to $83.0 million in 2023, then dropped by 29.23% to $58.7 million in 2024, then rose by 8.45% to $63.7 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for ZLAB at $63.7 million in Q4 2025, $51.5 million in Q3 2025, and $44.1 million in Q2 2025.